Journal
PHARMACEUTICS
Volume 13, Issue 8, Pages -Publisher
MDPI
DOI: 10.3390/pharmaceutics13081300
Keywords
curcumin; beclomethasone dipropionate; nanosuspension; asthma; pulmonary delivery; NGI; DSC; XRPD; ATR-FTIR
Categories
Funding
- UniCA-Progetti biennali di Ateneo Finanziati dalla Fondazione di Sardegna [CUP F74I19000950007]
Ask authors/readers for more resources
Curcumin, when formulated as nanosuspensions, shows potential as an effective component in asthma treatment. The optimized Curcumin nanosuspension exhibited improved stability and solubility, while the multicomponent formulation also showed good stability and particle size distribution over 90 days. Nebulization tests of the samples demonstrated optimal aerodynamic parameters and mass median aerodynamic diameter below 5 μm.
Curcumin has shown a potential extraordinary activity as an add-on ingredient in asthma treatment, due to its immunomodulatory and anti-inflammatory mechanism of action. However, its low water solubility and bioavailability lead to a poor therapeutic effect, which can be overcome by its formulation as nanocrystals. The aim of this study was to prepare a multicomponent formulation for the delivery of curcumin (CUR) and beclomethasone dipropionate (BDP) into the lungs as water-based nanosuspensions (NS). Single component formulations (CUR-NS, BDP-NS) and a multicomponent formulation (CUR+BDP-NS) were prepared through a wet ball media milling technique, using P188 as a non-toxic stabilizer. Characterization was carried out in terms of size, size distribution, zeta potential, nanocrystals morphology, and solid-state properties. Moreover, the inhalation delivery efficiency was studied with Next Generation Impactor (NGI, Apparatus E Ph. Eu). CUR-NS was optimized and showed a long-term stability and improved nanocrystals apparent solubility. The three formulations exhibited a nanocrystal mean diameter in the range of 200-240 nm and a homogenous particle size distribution. Aggregation or sedimentation phenomena were not observed in the multicomponent formulation on 90 days storage at room temperature. Finally, the nebulization tests of the three samples showed optimal aerodynamic parameters and MMAD < 5 mu m.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available